- Brownlee M, Vlassara H, Kooney A, Ulrich P, Cerarni A. (1986). Aminoguanidine prevents diabetes-in-duced arterial wall protein cross-linking. Science 232: 1629–1632.
- Cerarni A, Vlassara H, Brownlee M. (1985). Protein glycosylation and the pathogenesis of atherosclerosis. Metabolism 34:37–42.
- Cerarni A, Vlassara H, Brownlee M. (1991). Glucose and Aging. In Cell Communication in Health and Dis- ease (H Rasmussen, Ed.) W. H. Freeman and Co. New York. 149–159.
- Frith CH, Suber L, Umholtz R. (1980). Hematologic and clinical chemistry finding in control BALB/c and C57BL/6 mice. Lab Anim Sci 30:835�840.
- Funk W, Endrich B, Messmer K, Intaglietta M. (1983). Spontaneous arteriolar vasomotion as a determinant of peripheral vascular resistance. Int J Microcirc Clin Exp 2:11�25.
- Geyer O, Almog J, Lupu MM, Lazar M, Oron Y. (1995). Nitric oxide synthase inhibitors protect rat retina against ischemic injury. FEBS Lett 374:399�402.
- Griffiths MJ, Messent M, Curzen NP, Evans TW. (1995). Aminoguanidine selectively decreases cyclic GMP levels produced by inducible nitric oxide synthase. Am J Respir Crit Care Med 152:1599�1604.
- Hayano J. (1988). Quantitative assessment of autonomic function by autoregressive spectral analysis of heart rate variability: effects of posture, respiration frequency and age. Jiritsusinkei 25:334�344.
- Iadecola C, Zhang F, Xu X. (1995). Inhibition of inducible nitric oxide synthase ameliorates cerebral
- Intaglietta M. (1981). Vasomotor activity, time de-pendent fluid exchange and tissue pressure. Micro-vasc Res 21:153–164.
- Intaglietta M, Gross JF. (1982). Vasomotion, tissue fluid and the formation of lymph. Int J Microcirc Clin Exp 1:55�56
- Kanai I, Kanai M. (1983). In Rinshokensahoteiyo, 29th Edition. (I Kanai and M Kanai, Eds.) Kanehara-Shuppan. Tokyo. 453–463.
- Kasten FH. (1993 ) . Introduction to fluorescent probes: Properties, history and applications. In Fluo-rescent and Luminescent Probes for Biological Activ-ity (WT Mason, Ed.) Academic Press Inc. San Diego, CA. 12–33.
- Knowles RG, Moncada S. (1994). Nitric oxide syn-thases in mammals. Biochem J 298:249–258.
- Laszlo F, Evans SM, Whittle BJ. (1995). Aminogua-nidine inhibits both constitutive and inducible nitric oxide synthase isoforms in rat intestinal microvascu-lature in vivo. Eur J Pharmacol 272:169–175.
- Leunig M, Yuan F, Menger M, Boucher Y, Goetz A, Messmer K, Jain RK. (1992). Angiogenesis, microvas-cular architechture, microhemodynarnics and inter-stitial fluid pressure during early growth of human adenocarcinoma L5174T in SCID mice. Cancer Res 52:6553–6560.
- National Nutrition Survey (1988). Supervised by Health Promotion and Nutrition Division, Health Ser-vice Bureau, Ministry of Health and Welfare. Tokyo. 75.
- National Nutrition Survey (1993). Supervised by Health Promotion and Nutrition Division, Health Ser-vice Bureau, Ministry of Health and Welfare. Tokyo. 87.
- Wolff DJ, Lubeskie A. (1995). Arninoguanidine is an isoform-selective, mechanism-based inactivator of ni-tric oxide synthase. Arch Biochem Biophys 316:290–301.
Microcirculation
Volume 6, 1999 - Issue 1